US0311621009 - Common Stock - After market: 253.65 0 (0%)
Date | Firm | Action | Rating |
---|---|---|---|
2023-01-19 | Piper Sandler | Maintains | Overweight |
2023-01-18 | Barclays | Maintains | Underweight |
2023-01-03 | Wells Fargo | Maintains | Equal-Weight |
2022-12-22 | SVB Leerink | Maintains | Market Perform |
2022-12-13 | Piper Sandler | Maintains | Overweight |
2022-12-06 | Oppenheimer | Maintains | Outperform |
2022-11-18 | Credit Suisse | Initiate | Underperform |
2022-11-04 | RBC Capital | Maintains | Sector Perform |
2022-11-04 | Morgan Stanley | Maintains | Overweight |
2022-11-04 | Piper Sandler | Maintains | Overweight |
2022-10-31 | Barclays | Downgrade | Equal-Weight -> Underweight |
2022-10-12 | Barclays | Maintains | Equal-Weight |
2022-10-11 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
2022-08-09 | Atlantic Equities | Maintains | Underweight |
2022-08-05 | RBC Capital | Maintains | Sector Perform |
2022-08-05 | Piper Sandler | Maintains | Overweight |
2022-07-15 | Morgan Stanley | Maintains | Equal-Weight |
2022-06-01 | Oppenheimer | Maintains | Outperform |
2022-05-23 | SVB Leerink | Initiate | Market Perform |
2022-05-10 | Mizuho | Maintains | Neutral |
2022-04-28 | BMO Capital | Maintains | Market Perform |
2022-04-28 | RBC Capital | Maintains | Sector Perform |
2022-04-28 | Piper Sandler | Maintains | Overweight |
2022-04-12 | Barclays | Maintains | Equal-Weight |
2022-04-12 | Morgan Stanley | Maintains | Equal-Weight |
2022-02-09 | Oppenheimer | Maintains | Outperform |
2022-02-09 | Barclays | Maintains | Equal-Weight |
2022-02-09 | Wells Fargo | Maintains | Equal-Weight |
2022-02-09 | Morgan Stanley | Maintains | Equal-Weight |
2022-01-05 | B of A Securities | Downgrade | Buy -> Neutral |
Find the competitors with the best analyst ratings on the USA